MXPA05011826A - Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46. - Google Patents
Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46.Info
- Publication number
- MXPA05011826A MXPA05011826A MXPA05011826A MXPA05011826A MXPA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A
- Authority
- MX
- Mexico
- Prior art keywords
- amino acid
- monoclonal antibody
- antibody binding
- probnp
- native probnp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03010591 | 2003-05-12 | ||
| PCT/EP2004/005092 WO2004099253A1 (en) | 2003-05-12 | 2004-05-12 | Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05011826A true MXPA05011826A (es) | 2006-01-26 |
Family
ID=33427054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05011826A MXPA05011826A (es) | 2003-05-12 | 2004-05-12 | Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46. |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US7264939B2 (https=) |
| EP (4) | EP1625164B1 (https=) |
| JP (4) | JP5128125B2 (https=) |
| KR (2) | KR100857752B1 (https=) |
| CN (3) | CN100497393C (https=) |
| AT (2) | ATE517124T1 (https=) |
| AU (1) | AU2004235974B2 (https=) |
| BR (1) | BRPI0410261B8 (https=) |
| CA (2) | CA2522747C (https=) |
| DK (3) | DK1625164T3 (https=) |
| ES (3) | ES2369008T3 (https=) |
| HU (1) | HUE025169T2 (https=) |
| MX (1) | MXPA05011826A (https=) |
| PL (3) | PL1625164T3 (https=) |
| WO (2) | WO2004099253A1 (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2843396B1 (fr) * | 2002-08-07 | 2005-04-15 | Bio Rad Pasteur | Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque |
| CN100497393C (zh) * | 2003-05-12 | 2009-06-10 | 霍夫曼-拉罗奇有限公司 | 用结合脑钠尿肽前体分子氨基酸41-46的单克隆抗体检测脑钠尿肽前体分子的方法 |
| US20070037208A1 (en) * | 2003-05-29 | 2007-02-15 | Foote Robert S | Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
| DE10355731A1 (de) | 2003-11-28 | 2005-06-30 | Roche Diagnostics Gmbh | Analytischer Sandwichtest zur Bestimmung von NT-proBNP |
| ATE364177T1 (de) * | 2004-07-07 | 2007-06-15 | Hoffmann La Roche | Kombinationen von markern zum nachweis von typ 1 und 2 diabetes |
| AT500800B1 (de) * | 2004-09-08 | 2008-07-15 | Biomedica Medizinprodukte Gmbh | Verfahren zur bestimmung von probnp |
| CN106908603B (zh) | 2007-01-25 | 2019-04-02 | 霍夫曼-拉罗奇有限公司 | Igfbp-7在心力衰竭评估中的用途 |
| KR100836322B1 (ko) * | 2007-08-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 흡음재 제작장치 및 방법 |
| US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
| ES2526928T3 (es) | 2008-04-30 | 2015-01-16 | The Governing Council Of The University Of Toronto | Uso de SFRP-3 en la evaluación de la insuficiencia cardíaca |
| CN102549436A (zh) | 2009-07-27 | 2012-07-04 | 霍夫曼-拉罗奇有限公司 | mimecan在评价心力衰竭中的用途 |
| CA2780301A1 (en) * | 2009-11-13 | 2011-05-19 | Bg Medicine, Inc. | Risk factors and prediction of myocardial infarction |
| US8778699B2 (en) | 2010-08-04 | 2014-07-15 | Idexx Laboratories, Inc. | Detection of degradation products of canine NT-proBNP |
| AU2012262154B2 (en) | 2011-05-31 | 2016-08-04 | Idexx Laboratories, Inc. | Detection of degradation products of feline NT-proBNP |
| JP6119607B2 (ja) * | 2011-09-20 | 2017-04-26 | コニカミノルタ株式会社 | 検体希釈用液、それを用いたキットおよび蛍光測定方法 |
| US20140273273A1 (en) | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
| CN103304665A (zh) * | 2013-05-21 | 2013-09-18 | 上海贝西生物科技有限公司 | 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用 |
| EP3206032B1 (en) * | 2014-10-10 | 2019-02-27 | Akira Matsumori | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure |
| EP3360570A1 (en) | 2017-02-13 | 2018-08-15 | Roche Diagnostics GmbH | Antibodies recognizing genetic variants |
| ES2948008T3 (es) | 2017-10-02 | 2023-08-25 | Otsuka Pharma Co Ltd | Método para detectar analito |
| EP3779438A4 (en) * | 2018-04-13 | 2022-01-26 | Kyoritsu Seiyaku Corporation | PROCEDURE FOR DETECTING HEART FAILURE, INSTRUMENT FOR DETECTING HEART FAILURE, SANDWICH IMMUNOASSAY PROCEDURE AND ANTIBODY COMBINATION |
| CN108752480B (zh) * | 2018-05-30 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 一种免疫原组合物、其制备方法及其用途 |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| CN111487222B (zh) * | 2019-01-28 | 2023-11-14 | 上海乐合生物科技有限公司 | 一种检测bnp的spr芯片的制备方法 |
| EP4014041A1 (en) | 2019-08-13 | 2022-06-22 | Gentian AS | Highly sensitive particle enhanced assay for the quantification of nt-probnp |
| US20230366894A1 (en) * | 2020-09-30 | 2023-11-16 | Roche Diagnostics Operations, Inc. | Circulating total-nt-probnp (glycosylated and unglycosylated nt-probnp) and its ratio with nt-probnp (unglycosylated nt-probnp) in the assessment of atrial fibrillation |
| CN112964885B (zh) * | 2021-02-20 | 2022-11-11 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
| CN112986586A (zh) * | 2021-02-20 | 2021-06-18 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
| EP4409297B1 (en) | 2021-10-01 | 2025-01-29 | Gentian AS | Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sample |
| JP2025508481A (ja) | 2022-03-18 | 2025-03-26 | エフ． ホフマン－ラ ロシュ アーゲー | ２型対１型の急性心筋梗塞の早期識別のためのトロポニンマーカーの組合せ |
| US20250232875A1 (en) | 2022-03-18 | 2025-07-17 | Roche Diagnostics Operations, Inc. | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
| WO2024219421A1 (ja) * | 2023-04-19 | 2024-10-24 | 栄研化学株式会社 | ＮＴ－ｐｒｏＢＮＰに対する抗体、これを用いたＮＴ－ｐｒｏＢＮＰ検出方法、並びに、ＮＴ－ｐｒｏＢＮＰ検出に用いるための組成物及びキット |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
| JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体 |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| ES2256952T3 (es) * | 1997-09-11 | 2006-07-16 | SHIONOGI & CO., LTD. | Inmunoanalisis para bnp. |
| GB9827348D0 (en) * | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
| PL204235B1 (pl) * | 1999-01-29 | 2009-12-31 | Roche Diagnostics Gmbh | Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych |
| US20030219734A1 (en) | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
| US20040096919A1 (en) * | 2002-11-18 | 2004-05-20 | Michelle Davey | Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
| CN100497393C (zh) * | 2003-05-12 | 2009-06-10 | 霍夫曼-拉罗奇有限公司 | 用结合脑钠尿肽前体分子氨基酸41-46的单克隆抗体检测脑钠尿肽前体分子的方法 |
-
2004
- 2004-05-12 CN CNB200480012494XA patent/CN100497393C/zh not_active Expired - Lifetime
- 2004-05-12 BR BRPI0410261A patent/BRPI0410261B8/pt not_active IP Right Cessation
- 2004-05-12 AT AT04732282T patent/ATE517124T1/de active
- 2004-05-12 EP EP04732282A patent/EP1625164B1/en not_active Expired - Lifetime
- 2004-05-12 CA CA2522747A patent/CA2522747C/en not_active Expired - Lifetime
- 2004-05-12 CN CNA2004800124973A patent/CN1784425A/zh active Pending
- 2004-05-12 PL PL04732282T patent/PL1625164T3/pl unknown
- 2004-05-12 AU AU2004235974A patent/AU2004235974B2/en not_active Expired
- 2004-05-12 EP EP15161853.5A patent/EP2949669A1/en not_active Ceased
- 2004-05-12 AT AT04732278T patent/ATE522546T1/de active
- 2004-05-12 WO PCT/EP2004/005092 patent/WO2004099253A1/en not_active Ceased
- 2004-05-12 JP JP2006505419A patent/JP5128125B2/ja not_active Expired - Lifetime
- 2004-05-12 DK DK04732282.1T patent/DK1625164T3/da active
- 2004-05-12 JP JP2006505418A patent/JP4430066B2/ja not_active Expired - Lifetime
- 2004-05-12 ES ES04732282T patent/ES2369008T3/es not_active Expired - Lifetime
- 2004-05-12 DK DK04732278.9T patent/DK1625163T3/da active
- 2004-05-12 KR KR1020057021327A patent/KR100857752B1/ko not_active Expired - Lifetime
- 2004-05-12 HU HUE10172014A patent/HUE025169T2/en unknown
- 2004-05-12 WO PCT/EP2004/005091 patent/WO2004099252A1/en not_active Ceased
- 2004-05-12 EP EP10172014.2A patent/EP2256132B1/en not_active Expired - Lifetime
- 2004-05-12 PL PL04732278T patent/PL1625163T3/pl unknown
- 2004-05-12 DK DK10172014.2T patent/DK2256132T3/en active
- 2004-05-12 EP EP04732278A patent/EP1625163B8/en not_active Expired - Lifetime
- 2004-05-12 ES ES10172014.2T patent/ES2548327T3/es not_active Expired - Lifetime
- 2004-05-12 CN CN2010101190838A patent/CN101967190A/zh active Pending
- 2004-05-12 PL PL10172014T patent/PL2256132T3/pl unknown
- 2004-05-12 MX MXPA05011826A patent/MXPA05011826A/es active IP Right Grant
- 2004-05-12 CA CA2522378A patent/CA2522378C/en not_active Expired - Lifetime
- 2004-05-12 ES ES04732278T patent/ES2372282T3/es not_active Expired - Lifetime
- 2004-05-12 KR KR1020087000782A patent/KR20080011467A/ko not_active Ceased
-
2005
- 2005-11-10 US US11/271,651 patent/US7264939B2/en not_active Expired - Lifetime
- 2005-11-10 US US11/271,138 patent/US7264938B2/en not_active Expired - Lifetime
-
2006
- 2006-12-05 US US11/634,286 patent/US7807380B2/en not_active Expired - Lifetime
- 2006-12-22 US US11/644,565 patent/US7811770B2/en not_active Expired - Lifetime
-
2009
- 2009-09-04 JP JP2009204610A patent/JP4834136B2/ja not_active Expired - Lifetime
-
2012
- 2012-10-04 JP JP2012222436A patent/JP5649631B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05011826A (es) | Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46. | |
| ATE486093T1 (de) | Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt | |
| WO2009004822A1 (ja) | 抗Muc17抗体 | |
| PT2185937E (pt) | Método para ensaiar septicemia em seres humanos | |
| DK1092155T3 (da) | Fremgangsmåde til tidlig diagnose af carcinomer | |
| GR1006896B (el) | Μεθοδος παραγωγης μιας πεπτιδικης ορμονης | |
| IL212056A0 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| WO2008012362A3 (en) | New protein isoforms and uses thereof | |
| ATE335763T1 (de) | Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden | |
| WO2012112013A3 (en) | A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer | |
| WO2009051427A3 (en) | A kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same | |
| WO2008125733A8 (en) | Immunoassay for quantification of an unstable antigen selected from bnp and probnp | |
| WO2004110369A3 (en) | Cell surface protein associated with human chronic lymphocytic leukemia | |
| WO2009054091A1 (ja) | ガストリン放出ペプチド前駆体に対する抗体及びその使用 | |
| WO2009044561A1 (ja) | 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体 | |
| MX2008000282A (es) | Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa. | |
| WO2008136510A1 (ja) | 自己免疫性膵炎及び劇症１型糖尿病の検査方法及び検査試薬 | |
| CA2440399A1 (en) | Epitope testing using hla | |
| WO2009045075A3 (en) | A monoclonal antibody specific to human embryonic stem cell, a hybridoma secreting the same and a method for detecting or isolating non-differenced embryonic stem cell | |
| WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
| DK1539817T3 (da) | Immunoassays til specifik bestemmelse af SCCA-isoformer | |
| EP1359161A3 (en) | Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof | |
| DE602005014782D1 (https=) | ||
| WO2009031351A1 (ja) | ウイルス抗原の検出方法及びウイルス抗原の検出キット | |
| AU2003256515A8 (en) | Method for identifying salt-sensitive persons |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |